您好,欢迎访问上海市农业科学院 机构知识库!

Ganoderic acid T, a novel activator of pyruvate carboxylase, exhibits potent anti-liver cancer activity

文献类型: 外文期刊

作者: Lei, Bo 1 ; Zhang, Mengjie 2 ; Shi, Xiangrui 4 ; Feng, Na 5 ; Yin, Jun 2 ; Dong, Rui 2 ; Xie, Chuanming 6 ; Zhu, Yinan 7 ; Zhong, Jian-Jiang 1 ; Ni, Bing 2 ;

作者机构: 1.Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China

2.Army Med Univ, Coll High Altitude Mil Med, Dept Pathophysiol, Chongqing 400038, Peoples R China

3.Minist Educ China, Key Lab Extreme Environm Med, Chongqing 400038, Peoples R China

4.Chongqing Univ, Sch Pharmaceut Sci, Chongqing Key Lab Nat Prod Synth & Drug Res, Chongqing 401331, Peoples R China

5.Shanghai Acad Agr Sci, Inst Edible Fungi, Shanghai, Peoples R China

6.Army Med Univ, Southwest Hosp, Dept Hepatobiliary Surg, Key Lab Hepatobiliary & Pancreat Surg, Chongqing, Peoples R China

7.Army Med Univ, Xinqiao Hosp, Dept Hepatobiliary Surg, Chongqing, Peoples R China

关键词: Hepatocellular carcinoma; Ganoderic acid T; Pyruvate carboxylase; Metabolic reprogramming; Allosteric activation

期刊名称:METABOLISM-CLINICAL AND EXPERIMENTAL ( 影响因子:11.9; 五年影响因子:11.8 )

ISSN: 0026-0495

年卷期: 2025 年 170 卷

页码:

收录情况: SCI

摘要: Background: Ganoderic acid T (GAT), a lanostane triterpenoid isolated from the methanol extract of G. lucidum mycelia, has demonstrated potent antitumor activity against various human cancer types. However, the specific molecular targets of GAT in cancer cells remain largely unknown. Therefore, this study systematically investigates these targets using the in vitro and in vivo hepatocellular carcinoma (HCC) model. Methods: The anti-tumor activities of GAT were validated in HCC cells, xenograft tumor models in nude mice, and patient-derived organoid models. The specific molecular target of GAT was identified through targeted fishing techniques. Experimental approaches such as proteomics, metabolomics, biotin pull-down assays, molecular docking studies, molecular dynamics simulations, DARTS, CETSA, and biolayer interferometry (BLI) were employed to confirm the binding between GAT and its molecular target as well as elucidate the underlying mechanism. Results: We have identified pyruvate carboxylase (PC) as a direct target of GAT. GAT, through its binding to the pocket composed of Arg453, Thr457, and Ile459 of PC, enhances the activity of PC, consequently disrupting the anaplerotic flux mediated by PC into the tricarboxylic acid (TCA) cycle. This disruption leads to impaired mitochondrial oxidative phosphorylation (OXPHOS) via the induction of reactive oxygen species (ROS)-mediated JNK/p38 MAPK signaling pathways, ultimately inhibiting HCC cell proliferation. Furthermore, molecular dynamics simulation suggests that GAT binds to and interacts with the biotin carboxylase (BC) domain of PC. This interaction potentially induces conformational changes in the protein structure of PC, leading to a tighter arrangement within the BC domain and stabilizing formation of a catalytically competent tetramer configuration for PC. The mutation of these key sites resulted in the destabilization of the BC domain and a reduction in the cytotoxic effect of GAT on HCC cells. Conclusion: Overall, these findings demonstrate that GAT directly targets PC through an allosteric mechanism, providing valuable insights into the anti-HCC properties of GAT.

  • 相关文献
作者其他论文 更多>>